Association of health insurance with outcomes in adults ages 18 to 64 years with melanoma in the United States

Journal of the American Academy of Dermatology

Volumn 74, Issue 2, 2016, Pages 309-316

  Amini, Arya ^a   Rusthoven, Chad G ^a   Waxweiler, Timothy V ^a   Jones, Bernard L ^a   Fisher, Christine M ^a   Karam, Sana D ^a   Raben, David ^a  

^a UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

Author keywords

Affordable Care Act; health care disparities; health insurance; malignant melanoma; treatment outcomes

Indexed keywords

ADULT; ADVANCED CANCER; ARTICLE; CANCER EPIDEMIOLOGY; CANCER RADIOTHERAPY; CANCER SURGERY; CANCER SURVIVAL; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; CUTANEOUS MELANOMA; FEMALE; HEALTH INSURANCE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAID; MEDICALLY UNINSURED; MIDDLE AGED; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RETROSPECTIVE STUDY; ULCER; UNITED STATES; YOUNG ADULT; CANCER REGISTRY; CANCER STAGING; KAPLAN MEIER METHOD; MELANOMA; MORTALITY; PATHOLOGY; SKIN NEOPLASMS; SKIN ULCER; STATISTICS AND NUMERICAL DATA; SURVIVAL RATE;

ADULT; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; INSURANCE, HEALTH; KAPLAN-MEIER ESTIMATE; MALE; MEDICAID; MEDICALLY UNINSURED; MELANOMA; MIDDLE AGED; NEOPLASM STAGING; RETROSPECTIVE STUDIES; SEER PROGRAM; SKIN NEOPLASMS; SKIN ULCER; SURVIVAL RATE; UNITED STATES; YOUNG ADULT;

EID: 84973407362     PISSN: 01909622     EISSN: 10976787     Source Type: Journal    
DOI: 10.1016/j.jaad.2015.09.054     Document Type: Article

References (23)

1. 1 Siegel, R.L., Miller, K.D., Jemal, A., Cancer statistics, 2015. CA Cancer J Clin 65 (2015), 5–29.
2. 2 Weir, H.K., Thompson, T.D., Soman, A., et al. The past, present, and future of cancer incidence in the United States: 1975 through 2020. Cancer 121 (2015), 1827–1837.
3. 3 Balch, C.M., Soong, S.J., Gershenwald, J.E., et al. Prognostic factors analysis of 17,600 melanoma patients: validation of the American Joint Committee on Cancer melanoma staging system. J Clin Oncol 19 (2001), 3622–3634.
4. 4 McArthur, G.A., Ribas, A., Targeting oncogenic drivers and the immune system in melanoma. J Clin Oncol 31 (2013), 499–506.
5. 5 Seidler, A.M., Pennie, M.L., Veledar, E., et al. Economic burden of melanoma in the elderly population: population-based analysis of the Surveillance, Epidemiology, and End Results (SEER)–Medicare data. Arch Dermatol 146 (2010), 249–256.
6. 6 Niu, X., Roche, L.M., Pawlish, K.S., et al. Cancer survival disparities by health insurance status. Cancer Med 2 (2013), 403–411.
7. 7 Walker, G.V., Grant, S.R., Guadagnolo, B.A., et al. Disparities in stage at diagnosis, treatment, and survival in nonelderly adult patients with cancer according to insurance status. J Clin Oncol 32 (2014), 3118–3125.
8. 8 Halpern, M.T., Ward, E.M., Pavluck, A.L., et al. Association of insurance status and ethnicity with cancer stage at diagnosis for 12 cancer sites: a retrospective analysis. Lancet Oncol 9 (2008), 222–231.
9. 9 SEER. Insurance Recode (2007+). Available from: http://seer.cancer.gov. Accessed June 1, 2015.
10. 10 SEER. Training modules, staging. Available from: URL: http://training.seer.cancer.gov/melanoma/abstract-code-stage/staging.html. Accessed June 1, 2015.
11. 11 Kleinbaum, D.G., Klein, M., Evaluating the proportional hazards assumption, survival analysis. 2012, Springer, New York, 161–200.
12. 12 Pollitt, R.A., Clarke, C.A., Shema, S.J., et al. California Medicaid enrollment and melanoma stage at diagnosis: a population-based study. Am J Prev Med 35 (2008), 7–13.
13. 13 Linos, E., Swetter, S.M., Cockburn, M.G., et al. Increasing burden of melanoma in the United States. J Invest Dermatol 129 (2009), 1666–1674.
14. 14 Wood, E., Sallar, A.M., Schechter, M.T., et al. Social inequalities in male mortality amenable to medical intervention in British Columbia. Soc Sci Med 48 (1999), 1751–1758.
15. 15 Roetzheim, R.G., Pal, N., Tennant, C., et al. Effects of health insurance and race on early detection of cancer. J Natl Cancer Inst 91 (1999), 1409–1415.
16. 16 Ayanian, J.Z., Kohler, B.A., Abe, T., et al. The relation between health insurance coverage and clinical outcomes among women with breast cancer. N Engl J Med 329 (1993), 326–331.
17. 17 Carrasquillo, O., Himmelstein, D.U., Woolhandler, S., et al. Can Medicaid managed care provide continuity of care to new Medicaid enrollees? An analysis of tenure on Medicaid. Am J Public Health 88 (1998), 464–466.
18. 18 Resneck, J. Jr., Pletcher, M.J., Lozano, N., Medicare, Medicaid, and access to dermatologists: the effect of patient insurance on appointment access and wait times. J Am Acad Dermatol 50 (2004), 85–92.
19. 19 Shi, L., Starfield, B., Kennedy, B., et al. Income inequality, primary care, and health indicators. J Fam Pract 48 (1999), 275–284.
20. 20 Guy, G.P. Jr., Ekwueme, D.U., Tangka, F.K., et al. Melanoma treatment costs: a systematic review of the literature, 1990–2011. Am J Prev Med 43 (2012), 537–545.
21. 21 Klatsky, A.L., Li, Y., Nicole Tran, H., et al. Alcohol intake, beverage choice, and cancer: a cohort study in a large Kaiser Permanente population. Perm J 19 (2015), 28–34.
22. 22 Fredrickson, A., Snyder, P.J., Cromer, J., et al. The use of effect sizes to characterize the nature of cognitive change in psychopharmacological studies: an example with scopolamine. Hum Psychopharmacol 23 (2008), 425–436.
23. 23 Rosenberg, A.R., Kroon, L., Chen, L., et al. Insurance status and risk of cancer mortality among adolescents and young adults. Cancer 121 (2015), 1279–1286.